Galectin Therapeutics Inc

Insiders Updates

GALT’s latest rating updates from top analysts.

Daniel Torres

Galectin Therapeutics Inc’s recent filing unveils that its Director ELDRED KARY acquired Company’s shares for reported $2611.0 on Dec 23 ...

News

GALT price target predicted to rise nearly 11 in 12 months

Daniel Torres

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or ...

Analysts Viewpoint

Galectin Therapeutics Inc [GALT] stock for 950,105 USD was sold by Shlevin Harold H.

Roman Campbell

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its ...

Analysts Viewpoint

Galectin Therapeutics Inc [NASDAQ: GALT] Sees Increase in Stock Value

Jaxson Clark

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its ...

Knox Daily
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.